Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q1)Apr 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 79.06%-253.24K | 265.23%491.19K | 62.92K | -384.06K | -423.29K | -1.21M | -297.27K | 0 | 0 | -350.82%-780.19K |
| Net income from continuing operations | 84.59%-1.03M | 106.39%313.42K | ---172.25K | ---522.22K | ---649.59K | ---6.69M | ---4.91M | --0 | --0 | -350.82%-780.19K |
| Depreciation and amortization | --0 | --0 | --0 | ---- | ---- | --833.33K | --277.78K | ---- | ---- | ---- |
| Asset impairment expenditure | --0 | ---- | ---- | ---- | ---- | --4.17M | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -58.85%178.77K | -242.03%-69.57K | --91.33K | ---11K | --168.01K | --434.41K | --48.98K | ---- | ---- | ---- |
| Change In working capital | 1,185.37%598.62K | 46.02%247.34K | --143.83K | --149.16K | --58.29K | --46.57K | --169.39K | --0 | ---- | --0 |
| -Change in receivables | ---26.69K | -101.93%-2.74K | ---2.16K | ---- | ---- | --0 | --142.06K | ---- | ---- | ---- |
| -Change in prepaid assets | 154.82%12.92K | -63.05%6.19K | --5.33K | ---9.95K | --11.35K | ---23.57K | --16.75K | --0 | ---- | ---- |
| -Change in payables and accrued expense | 260.08%252.56K | 807.34%96.02K | --143.91K | ---34.3K | --46.94K | --70.14K | --10.58K | --0 | ---- | ---- |
| -Change in other working capital | --359.83K | --147.88K | ---3.24K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 79.06%-253.24K | 265.23%491.19K | --62.92K | ---384.06K | ---423.29K | ---1.21M | ---297.27K | --0 | --0 | -350.82%-780.19K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 69.65%-272.99K | -529.14K | -205.68K | 234.97K | 226.86K | -899.39K | 0 | |||
| Net other investing changes | 69.65%-272.99K | ---529.14K | ---205.68K | --234.97K | --226.86K | ---899.39K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 69.65%-272.99K | ---529.14K | ---205.68K | --234.97K | --226.86K | ---899.39K | ---- | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -80.35%437.71K | 241.95%68.71K | 136.83K | 97.13K | 13,504,400.00%135.05K | 2.23M | 20.09K | 1 | 350.82%780.19K | |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --2.16M | --0 | --1 | ---- | 350.82%780.19K |
| Proceeds from stock option exercised by employees | 528.45%437.71K | 241.95%68.71K | --136.83K | --97.13K | --135.05K | --69.65K | --20.09K | --0 | ---- | ---- |
| Net other financing activities | ---1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -80.35%437.71K | 241.95%68.7K | --136.83K | --97.13K | 13,504,400.00%135.05K | --2.23M | --20.09K | --1 | --1 | 350.82%780.19K |
| Net cash flow | ||||||||||
| Beginning cash position | 11,978,300.00%119.78K | -99.96%501 | --6.25K | --58.2K | --119.78K | --1 | --1.3M | --0 | --0 | --0 |
| Current changes in cash | -174.10%-88.52K | 102.61%30.76K | ---5.94K | ---51.96K | -6,138,700.00%-61.39K | --119.47K | ---1.18M | --1 | --1 | ---- |
| Effect of exchange rate changes | --0 | --0 | --194 | --0 | ---194 | --318 | --0 | --0 | ---- | ---- |
| End cash Position | -73.90%31.26K | -73.90%31.26K | --501 | --6.25K | 5,820,300.00%58.2K | --119.78K | --119.78K | --1 | --1 | --0 |
| Free cash from | 79.06%-253.24K | 265.23%491.19K | --62.92K | ---384.06K | ---423.29K | ---1.21M | ---297.27K | --0 | --0 | -350.82%-780.19K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.